Similarly, the median inhibition of anti-HSA IgG by BSA was 68% (range 0–96%) with the median inhibition being more pronounced in SLE patients (74%) than in healthy controls (48%) (Figure 6A). This evidence concerns the gene ALB and systemic lupus erythematosus.